Search Results
10
Everything
Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer’s Disease
February 19, 2025 08:30 ET
|
Neurogen Biomarking
CHICAGO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Neurogen Biomarking, the world’s first ecosystem for memory and thinking concerns announced today that they have entered into an exclusive agreement to use...
Breast Cancer Liquid Biopsy Market to hit USD 1.9 billion by 2032, says Global Market Insights Inc.
January 06, 2025 04:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Breast cancer liquid biopsy market size reached USD 305.9 million in 2023 and is projected to expand at a robust CAGR of 22.6% from 2024 to...
Burning Rock Announces Results of 2024 Annual General Meeting
December 31, 2024 04:56 ET
|
Burning Rock Biotech Limited
Burning Rock Announces Results of 2024 Annual General Meeting
Burning Rock Reports Third Quarter 2024 Financial Results
December 03, 2024 23:59 ET
|
Burning Rock Biotech Limited
Burning Rock Reports Third Quarter 2024 Financial Results
Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024
December 03, 2024 06:45 ET
|
Burning Rock Biotech Limited
Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
November 05, 2024 09:00 ET
|
PrognomiQ
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
October 10, 2024 23:16 ET
|
Burning Rock Biotech Limited
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
Burning Rock Announces Changes to Management and Board of Directors
September 27, 2024 08:37 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR) (the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Reports Second Quarter 2024 Financial Results
August 22, 2024 23:59 ET
|
Burning Rock Biotech Limited
Burning Rock Reports Second Quarter 2024 Financial Results
Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares
August 19, 2024 02:21 ET
|
Burning Rock Biotech Limited
Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares